Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02605733 · ClinicalTrials.gov registry record
The Neu-Prem Trial: Neuromonitoring of Preterm Newborn Brain During Birth Resuscitation
A clinical trial, sponsored by Sharp HealthCare.
- Completed
- Registry status
- 130
- Enrollment target
NCT02605733: Completed study, sponsored by Sharp HealthCare.
NCT02605733 is a clinical trial that has completed, run by Sharp HealthCare. The registered enrollment target is 130 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02605733 has completed, sponsored by Sharp HealthCare.
- COMPLETED
- Registry status
- 130 participants
- Enrollment target
Study Summary
The purpose of this study is to characterize the normal brain function of premature infants (23 to 31+6 weeks GA) during birth transition and through the first 72 hours of life.
Interventions
- DEVICE EEG
- DEVICE NIRS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2015-10 |
| Est. Completion | 2021-05-13 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02605733
The ClinicalTrials.gov registry entry for NCT02605733 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sharp HealthCare, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which EEG is the first listed.
NCT02605733 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02605733 about?
NCT02605733 is a clinical study titled "The Neu-Prem Trial: Neuromonitoring of Preterm Newborn Brain During Birth Resuscitation". The purpose of this study is to characterize the normal brain function of premature infants (23 to 31+6 weeks GA) during birth transition and through the first 72 hours of life.
What is the current status of trial NCT02605733?
This trial is currently completed. The enrollment target is 130 participants. The study started on 2015-10. Estimated completion is 2021-05-13.
What interventions are being tested in trial NCT02605733?
The interventions under investigation include: EEG (DEVICE), NIRS (DEVICE).
Who is sponsoring clinical trial NCT02605733?
This trial is sponsored by Sharp HealthCare, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.